AZNN:BMV
AstraZeneca ADR Representing 0.5 Ord Shs
MX$1,628.00
0.00%
(0.00) 1D
Jan 30, 12:39:07 PM GMT-6 · MXN
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AZNN...
Mkt. cap
259.12B
Avg. vol.
0.00
Volume
0.00
52-wk high
MX$1,722.60
52-wk low
MX$1,396.91
Shares outstanding
1.27B
No. of employees
96K
Mkt. cap
259.12B
Avg. vol.
0.00
Volume
0.00
52-wk high
MX$1,722.60
52-wk low
MX$1,396.91
Shares outstanding
1.27B
No. of employees
96K
News stories
From web sources and news partners
TipRanks
·
2 hours ago
AstraZeneca’s New Asthma Care Trial Signals Long-Term Upside for Respiratory Investors
TipRanks
·
2 hours ago
AstraZeneca’s BalanceD-CKD Trial Targets Big Gains in Advanced Kidney Care
TipRanks
·
2 hours ago
AstraZeneca’s AZD6234 Trial Completion Adds New Catalyst in Obesity and Diabetes
Traders Union
·
10 hours ago
AstraZeneca stock outlook: Sellers keep short-term control amid weak momentum
Profile
AstraZeneca plc is a Swedish–British multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation.
The company was founded in 1999 through the merger of the Swedish Astra AB and the British Zeneca Group. Zeneca shareholders received 53.5% of the shares, while Astra shareholders received the remaining 46.5%. Its portfolio includes primary and speciality care, coverage for rare diseases, and a robust global presence across various regions. Since the merger it has been among the world's largest pharmaceutical companies and has made numerous corporate acquisitions, including Cambridge Antibody Technology, MedImmune, Spirogen and Definiens. It has its research and development concentrated in three strategic centres: Cambridge, England; Gothenburg, Sweden; and Gaithersburg, Maryland, US.
AstraZeneca traces its earliest corporate history to 1913, when Astra AB was formed by a large group of doctors and apothecaries in Södertälje. Wikipedia
About AstraZeneca ADR Representing 0.5 Ord Shs
CEOPascal Soriot
Employees96.1K
FoundedApr 6, 1999
HeadquartersCambridge, Cambridgeshire, United Kingdom
SectorPharmaceutical industry
Websiteastrazeneca.com